Product logins

Find logins to all Clarivate products below.


Facial Injectables | Medtech 360 | Market Analysis | Europe | 2017

The European facial injectables market will expand through 2025, fueled by high patient demand, economic recovery, product improvements, and an increasing number of practitioners offering these procedures. Nevertheless, tightening regulations and price competition will limit market growth slightly.

The large number of relatively homogeneous products in the market is forcing companies to innovate and increase their focus on promotions and marketing initiatives.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe
The European large-joint reconstructive implant market is poised for long-term sustained growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants,…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…